![]()
|
|
||||||||
From the
1 From the Divisions of General Medicine and Endocrinology and Metabolism, Department of Medicine, University of Miami School of Medicine, Miami, Florida 33152
Cyclic adenosine 3',5'-monophosphate at 5 x 10-5 m decreased the incorporation of [2-14C]acetate into fatty acid (36 ± 5%) in rat liver slices. Concentrations of cyclic adenosine 3',5'-monophosphate of 5 x 10-3 m and higher decreased cholesterol synthesis by more than 80%. The dibutyryl analog of the nucleotide produced a similar significant inhibition of fatty acid synthesis and cholesterol synthesis, but at concentrations up to 100-fold less. Metabolic evolution of CO2 was not significantly depressed at any concentration of either nucleotide. The data indicate that cyclic adenosine 3',5'-monophosphate may be involved in regulating acetyl-CoA incorporation into de novo fatty acid and cholesterol in a specific manner in mammalian liver.
Evidence for Regulation of Cholesterol and Fatty Acid Synthesis in Liver by Cyclic Adenosine 3',5'-Monophosphate
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Augustyn and F. Ziegler Endogenous cyclic adenosine monophosphate in tissues of rabbits fed an atherogenic diet Science, February 7, 1975; 187(4175): 449 - 450. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |